Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
65.01 CHF | +40.51% | -.--% | +40.51% |
05-31 | Raymond James Adjusts Price Target on Charles Schwab to $80 From $78 | MT |
05-31 | JPMorgan Adjusts Price Target on Charles Schwab to $81 From $89 | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Investment Banking & Brokerage Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+40.51% | 134B | - | ||
+4.92% | 159B | C- | ||
+18.34% | 155B | C+ | ||
+21.13% | 119B | C+ | ||
-8.59% | 35.44B | B+ | ||
+10.10% | 25.44B | B | ||
+25.74% | 21.38B | B+ | ||
-9.42% | 19.99B | B+ | ||
+49.05% | 18.02B | B | ||
+4.03% | 15.6B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SCHW Stock
- Stock
- Ratings Charles Schwab